The Massive Deal That Could Send This Biotech Into A Break Out biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
Agios Pharmaceuticals, Inc. announced that the company has agreed to sell its rights to its 15% royalty on potential U.S. net sales of Servier?s vorasidenib to Royalty Pharma. Under the terms of the.